Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2012, Article ID 582018, 6 pages
http://dx.doi.org/10.1155/2012/582018
Research Article

Spatiotemporal Dysfunction of the Vascular Permeability Barrier in Transgenic Mice with Sickle Cell Disease

1Aflac Cancer and Blood Disorders Center, Division of Hematology/Oncology/BMT, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA
2Department of Pediatrics, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA

Received 16 December 2011; Accepted 15 February 2012

Academic Editor: Kenneth R. Peterson

Copyright © 2012 Samit Ghosh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Embury, R. P. Hebbel, N. Mohandas, and M. H. Steinberg, Sickle Cell Disease: Basic Principles and Clinical Practice, Raven Press, New York, NY, USA, 1995.
  2. G. J. Kato, M. T. Gladwin, and M. H. Steinberg, “Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes,” Blood Reviews, vol. 21, no. 1, pp. 37–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. A. Bensinger and P. N. Gillette, “Hemolysis in sickle cell disease,” Archives of Internal Medicine, vol. 133, no. 4, pp. 624–631, 1974. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Aird, Endothelial Biomedicine, Cambridge University Press, 2007.
  5. M. H. Steinberg, “Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches,” TheScientificWorldJournal, vol. 8, pp. 1295–1324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. Duits, R. C. Pieters, A. W. Saleh et al., “Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis,” Clinical Immunology and Immunopathology, vol. 81, no. 1, pp. 96–98, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Solovey, Y. Lin, P. Browne, S. Choong, E. Wayner, and R. P. Hebbel, “Circulating activated endothelial cells in sickle cell anemia,” New England Journal of Medicine, vol. 337, no. 22, pp. 1584–1590, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Solovey, L. Gui, N. S. Key, and R. P. Hebbel, “Tissue factor expression by endothelial cells in sickle cell anemia,” Journal of Clinical Investigation, vol. 101, no. 9, pp. 1899–1904, 1998. View at Google Scholar · View at Scopus
  9. J. D. Belcher, C. J. Bryant, J. Nguyen et al., “Transgenic sickle mice have vascular inflammation,” Blood, vol. 101, no. 10, pp. 3953–3959, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. A. Manci, C. A. Hillery, C. A. Bodian, Z. G. Zhang, G. A. Lutty, and B. S. Coller, “Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease,” Blood, vol. 107, no. 4, pp. 1651–1658, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. L. L. Hsu, H. C. Champion, S. A. Campbell-Lee et al., “Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability,” Blood, vol. 109, no. 7, pp. 3088–3098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. T. Gladwin, V. Sachdev, M. L. Jison et al., “Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease,” New England Journal of Medicine, vol. 350, no. 9, pp. 886–895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. K. Graham, M. Mosunjac, R. L. Hanzlick, and M. Mosunjac, “Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review,” American Journal of Forensic Medicine and Pathology, vol. 28, no. 2, pp. 168–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. P. Vichinsky, L. D. Neumayr, A. N. Earles et al., “Causes and outcomes of the acute chest syndrome in sickle cell disease,” New England Journal of Medicine, vol. 342, no. 25, pp. 1855–1865, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Pászty, C. M. Brion, E. Manci et al., “Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease,” Science, vol. 278, no. 5339, pp. 876–878, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. L. C. Wu, C. W. Sun, T. M. Ryan, K. M. Pawlik, J. Ren, and T. M. Townes, “Correction of sickle cell disease by homologous recombination in embryonic stem cells,” Blood, vol. 108, no. 4, pp. 1183–1188, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. D. Reiter, X. Wang, J. E. Tanus-Santos et al., “Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease,” Nature Medicine, vol. 8, no. 12, pp. 1383–1389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. T. Gladwin, V. Sachdev, M. L. Jison et al., “Pulmonary hypertension as a risk factor for death in patients with sickle cell disease,” New England Journal of Medicine, vol. 350, no. 9, pp. 886–895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. P. Hebbel, R. Osarogiagbon, and D. Kaul, “The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy,” Microcirculation, vol. 11, no. 2, pp. 129–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. B. N. Y. Setty and M. J. Stuart, “Vascular cell adhesion molecule-1 is involved in mediating hypoxia- induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease,” Blood, vol. 88, no. 6, pp. 2311–2320, 1996. View at Google Scholar · View at Scopus
  21. J. K. Graham, M. Mosunjac, R. L. Hanzlick, and M. Mosunjac, “Sickle cell lung disease and sudden death: a retrospective/prospective study of 21 autopsy cases and literature review,” American Journal of Forensic Medicine and Pathology, vol. 28, no. 2, pp. 168–172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Girard, “Case report: postoperative pulmonary edema and sickle cell crisis,” Clinical Notes on Respiratory Diseases, vol. 17, no. 4, pp. 13–14, 1979. View at Google Scholar · View at Scopus
  23. K. L. Wallace, M. A. Marshall, S. I. Ramos et al., “NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines,” Blood, vol. 114, no. 3, pp. 667–676, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Masedunskas, J. A. King, F. Tan et al., “Activated leukocyte cell adhesion molecule is a component of the endothelial junction involved in transendothelial monocyte migration,” FEBS Letters, vol. 580, no. 11, pp. 2637–2645, 2006. View at Publisher · View at Google Scholar · View at Scopus